The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates
Open accessAbstract
Over the past two decades the number of opioid pain relievers sold in the United States rose dramatically. This rise in sales was accompanied by an increase in opioid-related overdose deaths. In response, forty-nine states (all but Missouri) created prescription drug monitoring programs to detect high-risk prescribing and patient behaviors. Our objectives were to determine whether the implementation or particular characteristics of the programs were effective in reducing opioid-related overdose deaths. In adjusted analyses we found that a state's implementation of a program was associated with an average reduction of 1.12 opioid-related overdose deaths per 100,000 population in the year after implementation. Additionally, states whose programs had robust characteristics-including monitoring greater numbers of drugs with abuse potential and updating their data at least weekly-had greater reductions in deaths, compared to states whose programs did not have these characteristics. We estimate that if Missouri adopted a prescription drug monitoring program and other states enhanced their programs with robust features, there would be more than 600 fewer overdose deaths nationwide in 2016, preventing approximately two deaths each day.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overadjustment bias and unnecessary adjustment in epidemiologic studies.
Schisterman, E. F., Cole, S. R., & Platt, R. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a819a1 · Cited by 2,096
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,529
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,015
Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012) · JAMA · doi:10.1001/jama.2012.3951 · Cited by 907
Self-citationPatterns of abuse among unintentional pharmaceutical overdose fatalities
Hall, A. J. (2008) · JAMA · doi:10.1001/jama.2008.802 · Cited by 815
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4005 · Cited by 695
Pharmaceutical Overdose Deaths, United States, 2010
Jones, C. M., Mack, K. A., & Paulozzi, L. J. (2013) · JAMA · doi:10.1001/jama.2013.272 · Cited by 678
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640
Patrick, S. W., Davis, M. M., Lehmann, C. U., & Cooper, W. O. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.36 · Cited by 629
Self-citation
Cited by
Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0865 · Cited by 873
Do medical marijuana laws reduce addictions and deaths related to pain killers?
Powell, D., Pacula, R. L., & Jacobson, M. (2018) · Journal of Health Economics · doi:10.1016/j.jhealeco.2017.12.007 · Cited by 345
Opioid-related mortality in rural America: Geographic heterogeneity and intervention strategies
Rigg, K. K., Monnat, S. M., & Chavez, M. N. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.04.011 · Cited by 294
Today’s fentanyl crisis: Prohibition’s Iron Law, revisited
Beletsky, L., & Davis, C. S. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.050 · Cited by 283
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7621 · Cited by 274
The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare
Buchmueller, T. C., & Carey, C. (2018) · American Economic Journal: Economic Policy · doi:10.1257/pol.20160094 · Cited by 257
Ali, M. M., Dowd, W. N., Classen, T., Mutter, R., & Novak, S. P. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.01.011 · Cited by 153
Rhodes, E., Wilson, M., Robinson, A., Hayden, J. A., & Asbridge, M. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4642-8 · Cited by 103
Strategies and policies to address the opioid epidemic: a case study of Ohio
Penm, J., MacKinnon, N. J., Boone, J. M., Ciaccia, A., McNamee, C., & Winstanley, E. L. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.01.001 · Cited by 73
Pauly, N. J., Slavova, S., Delcher, C., Freeman, P. R., & Talbert, J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.002 · Cited by 63
YARAGHI, N., & GOPAL, R. D. (2018) · The Milbank Quarterly · doi:10.1111/1468-0009.12314 · Cited by 43
Metadata
- Authors
- Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2016-07
- Volume
- 35
- Issue
- 7
- Pages
- 1324-1332
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2466771592
- Cited by
- 299
- References
- 30
- FWCI
- 48.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.